Andrew N Yan (Q50357): Difference between revisions
From geokb
(Created a new Item: Added new record for a person from the USGS Staff Profile inventory listing) |
(Changed an Item: added Wikidata same as link) |
||||||||||||||
(16 intermediate revisions by the same user not shown) | |||||||||||||||
aliases / en / 0 | aliases / en / 0 | ||||||||||||||
and Li Yan | |||||||||||||||
aliases / en / 1 | aliases / en / 1 | ||||||||||||||
Andrew Yan | |||||||||||||||
aliases / en / 2 | aliases / en / 2 | ||||||||||||||
Adela Jingyi Yan | |||||||||||||||
aliases / en / 3 | aliases / en / 3 | ||||||||||||||
Anthea Yan | |||||||||||||||
aliases / en / 4 | aliases / en / 4 | ||||||||||||||
Amy Suen Ka Yan | |||||||||||||||
aliases / en / 5 | aliases / en / 5 | ||||||||||||||
A.T Yan | |||||||||||||||
aliases / en / 6 | aliases / en / 6 | ||||||||||||||
Allied Yan | |||||||||||||||
aliases / en / 7 | aliases / en / 7 | ||||||||||||||
Andrew T. Yan | |||||||||||||||
aliases / en / 8 | aliases / en / 8 | ||||||||||||||
A.J. Yan | |||||||||||||||
aliases / en / 9 | aliases / en / 9 | ||||||||||||||
A. Yan | |||||||||||||||
aliases / en / 10 | aliases / en / 10 | ||||||||||||||
Andrew Tze‐Kay Yan | |||||||||||||||
aliases / en / 11 | aliases / en / 11 | ||||||||||||||
Ailing YAN | |||||||||||||||
aliases / en / 12 | aliases / en / 12 | ||||||||||||||
A. T. Yan | |||||||||||||||
description / en | description / en | ||||||||||||||
Computer Scientist | Computer Scientist with the Water Resources Mission Area | ||||||||||||||
Property / instance of: person / reference | |||||||||||||||
Property / employer | |||||||||||||||
Property / employer: United States Geological Survey / rank | |||||||||||||||
Property / employer: United States Geological Survey / qualifier | |||||||||||||||
| |||||||||||||||
Property / employer: United States Geological Survey / reference | |||||||||||||||
Property / reference URL | |||||||||||||||
Property / reference URL: https://www.usgs.gov/staff-profiles/andrew-n-yan / rank | |||||||||||||||
Property / reference URL: https://www.usgs.gov/staff-profiles/andrew-n-yan / qualifier | |||||||||||||||
| |||||||||||||||
Property / reference URL: https://www.usgs.gov/staff-profiles/andrew-n-yan / reference | |||||||||||||||
Property / email address: mailto:ayan@usgs.gov / qualifier | |||||||||||||||
point in time: 12 May 2024
| |||||||||||||||
Property / email address: mailto:ayan@usgs.gov / qualifier | |||||||||||||||
| |||||||||||||||
Property / email address: mailto:ayan@usgs.gov / reference | |||||||||||||||
Property / email address: mailto:ayan@usgs.gov / reference | |||||||||||||||
Property / is affiliated with | |||||||||||||||
Property / is affiliated with: Q44327 (Deleted Item) / rank | |||||||||||||||
Property / is affiliated with: Q44327 (Deleted Item) / qualifier | |||||||||||||||
| |||||||||||||||
Property / is affiliated with: Q44327 (Deleted Item) / reference | |||||||||||||||
Property / ORCID iD | |||||||||||||||
Property / ORCID iD: 0000-0002-2063-7485 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / ORCID iD: 0000-0002-2063-7485 / qualifier | |||||||||||||||
point in time: 30 January 2024
| |||||||||||||||
Property / ORCID iD: 0000-0002-2063-7485 / qualifier | |||||||||||||||
status code: 200 | |||||||||||||||
Property / ORCID iD: 0000-0002-2063-7485 / qualifier | |||||||||||||||
last update: 23 May 2024
| |||||||||||||||
Property / ORCID iD: 0000-0002-2063-7485 / qualifier | |||||||||||||||
retrieved: 23 May 2024
| |||||||||||||||
Property / ORCID iD: 0000-0002-2063-7485 / reference | |||||||||||||||
Property / official website | |||||||||||||||
Property / official website: https://www.usgs.gov/staff-profiles/andrew-n-yan / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / official website: https://www.usgs.gov/staff-profiles/andrew-n-yan / qualifier | |||||||||||||||
retrieved: 18 September 2024
| |||||||||||||||
Property / official website: https://www.usgs.gov/staff-profiles/andrew-n-yan / qualifier | |||||||||||||||
status code: 200 | |||||||||||||||
Property / official website: https://www.usgs.gov/staff-profiles/andrew-n-yan / qualifier | |||||||||||||||
last update: 21 September 2024
| |||||||||||||||
Property / employer | |||||||||||||||
Property / employer: United States Geological Survey / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / employer: United States Geological Survey / qualifier | |||||||||||||||
point in time: 12 May 2024
| |||||||||||||||
Property / employer: United States Geological Survey / reference | |||||||||||||||
Property / is affiliated with | |||||||||||||||
Property / is affiliated with: Water Resources Mission Area / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / is affiliated with: Water Resources Mission Area / qualifier | |||||||||||||||
point in time: 12 May 2024
| |||||||||||||||
Property / is affiliated with: Water Resources Mission Area / reference | |||||||||||||||
Property / occupation | |||||||||||||||
Property / occupation: computer scientist / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / occupation: computer scientist / qualifier | |||||||||||||||
point in time: 12 May 2024
| |||||||||||||||
Property / occupation: computer scientist / reference | |||||||||||||||
Property / OpenAlex ID | |||||||||||||||
Property / OpenAlex ID: A5016160940 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / OpenAlex ID: A5016160940 / qualifier | |||||||||||||||
retrieved: 23 May 2024
| |||||||||||||||
Property / OpenAlex ID: A5016160940 / qualifier | |||||||||||||||
last update: 22 May 2024
| |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Management of Acute Myocardial Infarction / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Management of Acute Myocardial Infarction / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Management of Acute Myocardial Infarction / qualifier | |||||||||||||||
prevalence: 135
| |||||||||||||||
Property / knows about: Management of Acute Myocardial Infarction / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Advanced Cardiac Imaging Techniques and Diagnostics / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Advanced Cardiac Imaging Techniques and Diagnostics / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Advanced Cardiac Imaging Techniques and Diagnostics / qualifier | |||||||||||||||
prevalence: 124
| |||||||||||||||
Property / knows about: Advanced Cardiac Imaging Techniques and Diagnostics / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Recommendations for Cardiac Chamber Quantification by Echocardiography / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Recommendations for Cardiac Chamber Quantification by Echocardiography / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Recommendations for Cardiac Chamber Quantification by Echocardiography / qualifier | |||||||||||||||
prevalence: 59
| |||||||||||||||
Property / knows about: Recommendations for Cardiac Chamber Quantification by Echocardiography / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Atrial Fibrillation group of topics / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Atrial Fibrillation group of topics / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Atrial Fibrillation group of topics / qualifier | |||||||||||||||
prevalence: 48
| |||||||||||||||
Property / knows about: Atrial Fibrillation group of topics / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Antiplatelet Therapy in Cardiovascular Disease / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Antiplatelet Therapy in Cardiovascular Disease / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Antiplatelet Therapy in Cardiovascular Disease / qualifier | |||||||||||||||
prevalence: 45
| |||||||||||||||
Property / knows about: Antiplatelet Therapy in Cardiovascular Disease / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Management of Diabetes Mellitus and Cardiovascular Risk / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Management of Diabetes Mellitus and Cardiovascular Risk / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Management of Diabetes Mellitus and Cardiovascular Risk / qualifier | |||||||||||||||
prevalence: 44
| |||||||||||||||
Property / knows about: Management of Diabetes Mellitus and Cardiovascular Risk / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Clinical Studies on Coronary Stents and Revascularization / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Clinical Studies on Coronary Stents and Revascularization / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Clinical Studies on Coronary Stents and Revascularization / qualifier | |||||||||||||||
prevalence: 44
| |||||||||||||||
Property / knows about: Clinical Studies on Coronary Stents and Revascularization / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Diagnosis and Treatment of Heart Failure / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Diagnosis and Treatment of Heart Failure / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Diagnosis and Treatment of Heart Failure / qualifier | |||||||||||||||
prevalence: 40
| |||||||||||||||
Property / knows about: Diagnosis and Treatment of Heart Failure / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Molecular Mechanisms of Cardiac Arrhythmias / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Molecular Mechanisms of Cardiac Arrhythmias / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Molecular Mechanisms of Cardiac Arrhythmias / qualifier | |||||||||||||||
prevalence: 38
| |||||||||||||||
Property / knows about: Molecular Mechanisms of Cardiac Arrhythmias / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Health Economics and Quality of Life Assessment / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Health Economics and Quality of Life Assessment / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Health Economics and Quality of Life Assessment / qualifier | |||||||||||||||
prevalence: 29
| |||||||||||||||
Property / knows about: Health Economics and Quality of Life Assessment / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Cardiotoxicity of Cancer Treatments / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Cardiotoxicity of Cancer Treatments / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Cardiotoxicity of Cancer Treatments / qualifier | |||||||||||||||
prevalence: 28
| |||||||||||||||
Property / knows about: Cardiotoxicity of Cancer Treatments / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Magnetic Resonance Imaging Applications in Medicine / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Magnetic Resonance Imaging Applications in Medicine / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Magnetic Resonance Imaging Applications in Medicine / qualifier | |||||||||||||||
prevalence: 26
| |||||||||||||||
Property / knows about: Magnetic Resonance Imaging Applications in Medicine / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy / qualifier | |||||||||||||||
prevalence: 20
| |||||||||||||||
Property / knows about: Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Management of Hypertension and Cardiovascular Risk Factors / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Management of Hypertension and Cardiovascular Risk Factors / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Management of Hypertension and Cardiovascular Risk Factors / qualifier | |||||||||||||||
prevalence: 19
| |||||||||||||||
Property / knows about: Management of Hypertension and Cardiovascular Risk Factors / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Cardiac Resynchronization Therapy in Heart Failure / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Cardiac Resynchronization Therapy in Heart Failure / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Cardiac Resynchronization Therapy in Heart Failure / qualifier | |||||||||||||||
prevalence: 19
| |||||||||||||||
Property / knows about: Cardiac Resynchronization Therapy in Heart Failure / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Pancreatic Islet Dysfunction and Regeneration / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Pancreatic Islet Dysfunction and Regeneration / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Pancreatic Islet Dysfunction and Regeneration / qualifier | |||||||||||||||
prevalence: 18
| |||||||||||||||
Property / knows about: Pancreatic Islet Dysfunction and Regeneration / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Role of AMP-Activated Protein Kinase in Cellular Metabolism / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Role of AMP-Activated Protein Kinase in Cellular Metabolism / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Role of AMP-Activated Protein Kinase in Cellular Metabolism / qualifier | |||||||||||||||
prevalence: 17
| |||||||||||||||
Property / knows about: Role of AMP-Activated Protein Kinase in Cellular Metabolism / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Chronic Kidney Disease and Dialysis Treatment / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Chronic Kidney Disease and Dialysis Treatment / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Chronic Kidney Disease and Dialysis Treatment / qualifier | |||||||||||||||
prevalence: 17
| |||||||||||||||
Property / knows about: Chronic Kidney Disease and Dialysis Treatment / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Cholesterol-lowering Treatment / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Cholesterol-lowering Treatment / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Cholesterol-lowering Treatment / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Cholesterol-lowering Treatment / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Catheter Ablation of Cardiac Arrhythmias / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Catheter Ablation of Cardiac Arrhythmias / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Catheter Ablation of Cardiac Arrhythmias / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Catheter Ablation of Cardiac Arrhythmias / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Prevention and Treatment of Venous Thromboembolism / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Prevention and Treatment of Venous Thromboembolism / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Prevention and Treatment of Venous Thromboembolism / qualifier | |||||||||||||||
prevalence: 12
| |||||||||||||||
Property / knows about: Prevention and Treatment of Venous Thromboembolism / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Cardiac Rehabilitation and Cardiovascular Health Interventions / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Cardiac Rehabilitation and Cardiovascular Health Interventions / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Cardiac Rehabilitation and Cardiovascular Health Interventions / qualifier | |||||||||||||||
prevalence: 12
| |||||||||||||||
Property / knows about: Cardiac Rehabilitation and Cardiovascular Health Interventions / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Management of Valvular Heart Disease / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Management of Valvular Heart Disease / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Management of Valvular Heart Disease / qualifier | |||||||||||||||
prevalence: 11
| |||||||||||||||
Property / knows about: Management of Valvular Heart Disease / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: HER2 Signaling in Breast Cancer Treatment / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: HER2 Signaling in Breast Cancer Treatment / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: HER2 Signaling in Breast Cancer Treatment / qualifier | |||||||||||||||
prevalence: 10
| |||||||||||||||
Property / knows about: HER2 Signaling in Breast Cancer Treatment / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Gender Bias in Biomedical Research / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Gender Bias in Biomedical Research / qualifier | |||||||||||||||
point in time: 22 May 2024
| |||||||||||||||
Property / knows about: Gender Bias in Biomedical Research / qualifier | |||||||||||||||
prevalence: 10
| |||||||||||||||
Property / knows about: Gender Bias in Biomedical Research / reference | |||||||||||||||
Property / same as | |||||||||||||||
Property / same as: http://www.wikidata.org/entity/Q88161887 / rank | |||||||||||||||
Normal rank |
Latest revision as of 15:54, 4 October 2024
Computer Scientist with the Water Resources Mission Area
- and Li Yan
- Andrew Yan
- Adela Jingyi Yan
- Anthea Yan
- Amy Suen Ka Yan
- A.T Yan
- Allied Yan
- Andrew T. Yan
- A.J. Yan
- A. Yan
- Andrew Tze‐Kay Yan
- Ailing YAN
- A. T. Yan
Language | Label | Description | Also known as |
---|---|---|---|
English | Andrew N Yan |
Computer Scientist with the Water Resources Mission Area |
|
Statements
12 May 2024
12 May 2024
12 May 2024
12 May 2024
0 references
22 May 2024
135
1 reference
1 reference
22 May 2024
59
1 reference
22 May 2024
48
1 reference
1 reference
1 reference
1 reference
22 May 2024
40
1 reference
22 May 2024
38
1 reference
1 reference
22 May 2024
28
1 reference
1 reference
22 May 2024
20
1 reference
1 reference
1 reference
22 May 2024
18
1 reference
1 reference
22 May 2024
17
1 reference
22 May 2024
13
1 reference
22 May 2024
13
1 reference
1 reference
22 May 2024
12
1 reference
22 May 2024
11
1 reference
22 May 2024
10
1 reference
22 May 2024
10
1 reference